As FOXM1 accumulates in aged tissues, chemical or genetic abrogation of PGAM1-Chk1 binding impedes the protective role of FOXM1 in SnCs, inducing the death of senescent cells and alleviating dysfunction, including lung fibrosis, in vivo, indicating its potential efficacy as senotherapy. Here, FOXM1 is linked to pulmonary fibrosis.